Sorrento Tech Inc., previously called Roka Bioscience Inc., said it would delist its common stock from the Nasdaq Global Market.

The company expects the official delisting of the stock to become effective Dec. 29.

Roka Bioscience completed the sale of all of its assets to Rokabio Inc. for about $16.5 million in November and changed its name to Sorrento Tech Inc.

Sorrento Tech intends to file a certificate of dissolution with the state of Delaware on Dec. 28 and close its stock transfer books at the close of business on the same day.